Abstract:Introduction: Breast cancer (BC) is a prevailing malignancy among women, and its inconspicuous development contributes significantly to mortality. The RNA N6-methyladenosine (m6A) modification represents an emerging mechanism for gene expression regulation, with the active involvement of the YTH N6-methyladenosine RNA binding protein 3 (YTHDF3) in tumor progression across multiple cancer types. Nonetheless, its precise function in breast cancer necessitates further investigation. Methods: The expression of YTHDF3 in both cell lines and patient tissues was examined using Western blotting, reverse transcription quantitative PCR (RT-qPCR), and immunohistochemistry (IHC) techniques. Bioinformatics analysis of methylated RNA immunoprecipitation sequencing (MeRIP-seq) and transcriptome RNA sequencing (RNA-seq) data was employed to screen for the target genes of YTHDF3. The main focus of this study was to investigate the in vitro biological functions of YTHDF3. The specific binding of YTHDF3 to its target genes and its correlation with m6A methylation were studied through RNA pull-down, RNA immunoprecipitation, and co-immunoprecipitation experiments. The protein regulatory mechanisms of downstream genes of YTHDF3 were assessed using protein stability analysis. Furthermore, the biological functions of YTHDF3 and its target genes in breast cancer cells were validated through CRISPR-Cas9 technology and rescue experiments. Results: By constructing a risk model using the TCGA database, YTHDF3 was identified as a high-risk factor among m6A methylation factors. Subsequent investigations revealed its elevated expression in various subtypes of breast cancer, accompanied by poor prognosis. MeRIP-seq analysis further revealed fibroblast growth factor 2 (FGF2) as a downstream gene of YTHDF3. Knockdown of YTHDF3 in breast cancer cells led to significant inhibition of cell self-renewal, migration, and invasion abilities in vitro. Mechanistically, YTHDF3 specifically recognized the methylated transcript of FGF2 within its coding sequence (CDS) region, leading to the inhibition of FGF2 protein degradation. Moreover, depletion of FGF2 markedly suppressed the biological functions of breast cancer cells, while reducing FGF2 expression in YTHDF3-overexpressing breast cancer cell lines substantially alleviated the malignant progression. Conclusions: In summary, our study elucidates the role of YTHDF3 as an oncogene in maintaining FGF2 expression in BC cells through an m6A-dependent mechanism. Additionally, we provide a potential biomarker panel for prognostic prediction in BC.

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2

Functional Characterization of FBXL7 As a Novel Player in Human Cancers

Fbw7 Suppresses Metastasis Of Colorectal Cancer By Inhibiting Hif1 Alpha/Ceacam5 Functional Axis

Emerging Roles of the FBW 7 Tumour Suppressor in Stem Cell Differentiation

Data from FBW7 (F-Box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the C-Myc/txnip (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

FBW7 Suppresses Cell Proliferation and G2/M Cell Cycle Transition Via Promoting Γ-Catenin K63-linked Ubiquitylation.

SCF FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

FBW7 Loss Promotes Epithelial-to-mesenchymal Transition in Non-Small Cell Lung Cancer Through the Stabilization of Snail Protein.

FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner

Abstract 3155: the SCFFBW7 E3 Ubiquitin Ligase Targets Krüppel-like Factor 5 (KLF5) for Proteolysis in Breast Cancer

FBW7 Increases Chemosensitivity in Hepatocellular Carcinoma Cells Through Suppression of Epithelial-Mesenchymal Transition.

The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation

IGFBP7 Plays a Potential Tumor Suppressor Role Against Colorectal Carcinogenesis with Its Expression Associated with DNA Hypomethylation of Exon 1

YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylation

FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors

Low Expression of M6a Reader YTHDC1 Promotes Progression of Ovarian Cancer Via PIK3R1/STAT3/GANAB Axis.

FBXO16-mediated Hnrnpl Ubiquitination and Degradation Plays a Tumor Suppressor Role in Ovarian Cancer.

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase

Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations

The Fbw7 Tumor Suppressor Targets Klf5 For Ubiquitin-Mediated Degradation And Suppresses Breast Cell Proliferation